Several signaling pathways, including the CaMKII pathway, mitogen-activated protein kinase (MAPK), peroxisome proliferator-activated receptor (PPAR), PI3K/AKT, and oxidative stress response pathway, are involved in the progression of myocardial hypertrophy [6–9]. Here, AKT1 is linked to cardiac hypertrophy.